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Abstract
We have fabricated protein polymer-gold nanoparticle (P-GNP) nanocomposites that exhibit 
enhanced binding and delivery properties of the small hydrophobic molecule drug, curcumin, to 
the model breast cancer cell line, MCF-7. These hybrid biomaterials are constructed via in situ 
GNP templated-synthesis with genetically engineered histidine tags. The P-GNP nanocomposites 
exhibit enhanced small molecule loading, sustained release and increased uptake by MCF-7 cells. 
When compared to the proteins polymers alone, the P-GNPs demonstrate a greater than 7-fold 
increase in curcumin binding, a nearly 50% slower release profile and more than 2-fold increase in 
cellular uptake of curcumin. These results suggest that P-GNP nanocomposites serve as promising 
candidates for drug delivery vehicles.
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Introduction
The fabrication of multifunctional, stimuli-responsive organic-inorganic hybrid materials 
that can self-assemble into defined structures bears tremendous potential in drug delivery 
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and medicine [1–4]. The synthesis of hybrids combining stimuli responsive materials and 
gold nanoparticles (GNPs) has been explored in large part due to their unique properties [5–
9]. For example, a composite hydrogel material comprised of temperature-sensitive 
copolymers, N-isopropylacrylamide and acrylamide, embedded with GNPs, bearing a gold 
sulfide nanoshell designed to absorb and convert near-IR light to heat has been developed 
[10]. Upon light triggered activation, the copolymer, when entrapped with a small molecule 
drug, undergoes a conformational change that in turn leads to drug release [10]. Another 
example of using gold nanoparticles for triggered drug release relies on liposomal 
nanoparticles composed 1,2-dipalmitoylsn-glycero-3-phosphocholine, 1-palmitoyl-2-
hydroxy-sn-glycero-3-phosphocholine and 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[carboxy(polyethylene glycol)-2000] [11]. Such liposomes, when 
loaded with both GNPs and the hydrophilic drug calcein, when subjected to 532 nm laser 
treatments leads to light controlled calcein release due to microbubble cavitation of the 
liposome membrane[11]. While a wide range of synthetic materials have been developed 
and explored [10,12–14], proteins have attracted intense attention due to the fine molecular 
and conformational control of sequence and structure [15,16]. Recently, GNPs have been 
decorated with a library of cationic groups that complex non-covalently with green 
fluorescent protein (GFP) [17]. These GFP-GNP complexes have been employed in an array 
to chemically detect human serum proteins in complex serum. In this case, the strategy for 
construction of such protein-GNP hybrids rely on the covalent or non-covalent linkage of 
chemically pre-fabricated GNPs that have been synthesized under harsh organic solvents 
[18,19].
Specific chemical transformations are employed to prepare GNPs of discrete sizes and 
additional chemical steps are required to further decorate GNPs with key ligands as well as 
conjugate them with the macromolecule of interest [20]. Yet biological systems are able to 
fabricate GNPs under ambient conditions in situ through specific sequences [19,21–26]. We 
seek to generate multifunctional protein materials capable of: (i) templated-synthesis of 
inorganic nanoparticles in situ to fabricate organic-inorganic hybrids without the need for 
covalent bonding between each substituent part; (ii) encapsulating and stabilizing large 
payloads of small molecules; and (iii) modulating the delivery of small molecule 
chemotherapeutic drugs in clinically relevant cells (Figure 1).
Previously we have produced protein diblock copolymers comprised of two different self-
assembling domains (SADs): 1) an elastin-like peptide (E); and 2) the coiled-coil region of 
Cartilage Oligomeric Matrix protein (C) [27,28]. While the diblocks, EC and CE, exhibit 
different temperature dependent conformations and self-assembly [27], they bind to 
curcumin [28], a naturally occurring anti-inflammatory agent bearing chemoprevention 
effects [29]. Curcumin has been chosen not only for its chemotherapeutic properties against 
the breast cancer cell line MCF-7 but also because it is insoluble and degrades rapidly under 
physiological conditions [29,30]. A drug delivery system that can solubilize and stabilize 
labile molecules such as curcumin would have beneficial therapeutic applications [29].
Here, we employ the two diblocks E1C-His6 and CE1-His6 each bearing an N-terminal 
hexahistidine tag for the templated-synthesis of gold nanoparticles (GNPs) in situ to yield 
the nanocomposites E1C-His6-GNP and CE1-His6-GNP, respectively (Figure 1). These 
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protein polymers are selected due to their thermostability and superior small molecule 
binding abilities [31]. We hypothesize that such P-GNP nanocomposites will influence the 
thermoresponsiveness, drug binding capacity and release. Notably, E1C-His6-GNP and CE1-
His6-GNP demonstrate elevated inverse temperature transitions, improved small molecule 
loading capacity, sustained release and enhanced uptake by cancer cells when compared to 
protein polymers alone.
Materials and Methods
General
Yeast extract and curcumin were obtained from Acros Organics (Geel, Belgium). Tryptic soy 
agar and gold(III) chloride trihydrate were acquired from MP Biomedicals (Santa Ana, CA). 
Ampicillin, isopropyl β-D-1-thiogalactopyranoside (IPTG), imidazole, sodium monobasic 
phosphate, sodium dibasic phosphate, sodium dodecyl sulfate, sodium hydroxide, sodium 
chloride, sucrose, tris-hydrochloride, tryptone, PFU high fidelity, DpnI, ACS grade methanol 
and urea were obtained from Fisher Scientific (Pittsburgh, PA). 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), magnesium sulfate, nickel chloride, sodium 
borohydride were purchased from Sigma Aldrich (St. Louis, MO). Tricine was purchased 
from Alfa Aesar (Ward Hill, MA). Glacial acetic acid and Factor Xa cleavage kit were 
purchased from EMD Millipore (Rockland, MA). Ethyl acetate was purchased from 
Pharmco-AAPER (Brookfield, CT). Ethylenediaminetetraacetic acid (EDTA) and 
hydrochloric acid were acquired from VWR (Radnor, PA). HPLC grade methanol was 
obtained from Ricca Chemical Company (Arlington, TX). Sephadex™ G-25 medium beads 
were purchased from Amersham Pharmacia Biotech AB (Piscataway, NJ). Columns were 
purchased from Bio-Rad (Hercules, CA).
Site-directed mutagenesis
pQE30/CE1 and pQE30/E1C were employed for production of CE1-His6 and E1C-His6 
proteins in this study [31]. In order to generate proteins with Factor Xa IEGR cleavage site, 
site-directed mutagenesis was performed using the following primers: 5’-
cgcagtagcagcgagctcgcgcccttctatgtgatggtgatggtg-3’ and 5’-
cgcgctagccgcaatgcgcccttctatgtgatggtg atggtg-3’ and their reverse complements to generate 
PQE30/CE1-IGER and PQE30/E1C-IGER, respectively. Following the standard protocol for 
parent strand digestion using Dpn1, the resulting product was transformed into XL1-Blue 
cells for future use. Mutations were verified by DNA sequencing at Eurofins (Huntsville, 
AL).
Protein expression and purification
Biosynthesis and purification of CE1-His6, E1C-His6, CE1-IEGR and E1C-IEGR, was 
performed as previously described (Figure S1) [31]. Briefly, PQE30/CE1, PQE30/E1C, 
PQE30/CE1-IGER and PQE30/E1C-IGER were used to express the CE1-His6, E1C-His6, 
CE1-IEGR and E1C-IEGR proteins, respectively. All proteins were purified on a HiTrap 
IMAC FF column charged with nickel under denaturing conditions. For the negative control, 
CE1-IEGR and E1C-IEGR were dialyzed in 10 mM sodium phosphate buffer, pH 8.0, using 
SnakeSkin dialysis tubing (Thermo Scientific, 3.5 K MWCO). Factor Xa cleaves the protein 
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after IEGR site, removing the His-tag. This reaction occurs in 1 µL of 0.5 unit/µL enzyme, 
44 µL protein sample of 0.2 mg/mL concentration and 5 µL cleavage buffer (final cleavage 
buffer condition is 2 mM Tris-HCl, 50 mM NaCl, 0.5 mM CaCl2, pH 7.25). This ratio was 
scaled up to cleave 4 mL of the samples and cleavage reaction was allowed for 4 days at 
4°C. This solution containing cleaved protein, His-tag and Factor Xa was transferred into 
Factor Xa capture resin and then passed through nickel beads to isolate the cleaved CE1 and 
E1C (Figure S2). After confirming the purity using sodium dodecylsulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE), CE1-His6, E1C-His6, CE1 and E1C were dialyzed into 10 
mM sodium phosphate buffer, pH 8.0.
Gold nanoparticle templated-synthesis
A 0.1 M HAuCl4·3H2O solution (reactive gold solution) was prepared in dH2O. 
Approximately, 1.2 µL of the reactive gold solution was added into 300 µL of 10 µM protein 
sample, followed by gentle vortex for 10 minutes at room temperature. To the mixture, a 3.6 
µL freshly prepared 0.1 M NaBH4 solution in dH2O, was added to reduce Au3+ to Au0. The 
mixture was then gently rotated to prevent aggregation or uneven templated-synthesis. The 
reaction was carried at room temperature for 1 hour. The molar ratio of Au3+ to protein was 
40 to 1, while the NaBH4 to Au3+ ratio was 2.5 to 1. The resulting protein polymer-gold 
nanoparticle (P-GNP) nanocomposites were stored at room temperature for 1 hour before 
further characterization.
Absorbance spectroscopy
The absorbance spectrum from 200 nm – 1000 nm of each P-GNP nanocomposite was 
scanned using SpectraMax M2 (Molecular Devices) in UV-transparent 96 well microplate 
(Corning, half area flat bottom). As a control, buffer, CE1-His6 and E1C-His6, in addition to 
the cleaved CE1 and E1C proteins at pH 8 were scanned. All protein samples were prepared 
at 10 µM in 10 mM sodium phosphate buffer, pH 8.0.
Transmission electron microscopy
Transmission Electron Microscopy (TEM) was used to identify the nanometer-sized 
structures that resulted from self-assembly at room temperature. Samples were prepared in 
water at 10 µM concentrations in 10 mM sodium phosphate buffer pH 8.0. The samples were 
gently mixed and applied on a carbon coated 400 mesh Cu/Rh grids and negatively stained 
with 1% uranyl acetate as previously described [31]. The images of the samples were 
collected on a Phillips CM12 TEM instrument at 120 kV. The particle area and size were 
measured using Image J [32–34]. The protein particle sizes were determined from at least 
>130 particles, while sizes of the resulting GNPs were determined from at least >130 
particles via Image J [32–34]. A histogram of the GNP sizes was generated to determine the 
average size distribution.
Circular dichroism (CD) spectroscopy
Wavelength-dependent Circular Dichroism (CD) spectra were collected on a Jasco J-815 CD 
Spectrometer equipped with a PTC-423S single position Peltier temperature control system 
and counter-cooled with an Isotemp 3016S (Fisher Scientific) water bath. Samples were 
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loaded in a Hellma 218 quartz cuvette (500 µL, 1 mm path length). A far-UV temperature-
dependent wavelength scan from 185–260 nm as a function of temperature was completed 
for CE1-His6 and E1C-His6 in the absence and presence of GNPs at 0.2 mg/mL in 10 mM 
sodium phosphate buffer pH 8.0 at scan rate of 50 nm/min for a range of temperatures (25–
90°C) with 3 accumulation scans. At least two batches of separately purified proteins were 
measured. CD data was converted into mean residue molar ellipticity (MRW) via equation 
[θ]MRW = θ·MW/(10·n·C·l), where θ is in mdeg, MW is molecular weight, n is amino acid 
number in protein, C is concentration in mg/mL, l is path length in cm [35]. Fitting and 
calculation of protein secondary structure was processed with CDSSTR methods [36–38]. 
Parameters for the calculation using CDSSTR program were identical to our previously 
published work [31].
Turbidometry
The turbidometry, or inverse temperature transition (Tt), was determined via UV-Vis 
Spectrophotometer Cary-50 (Agilent Technology) equipped with TC 125 temperature 
controller (Quantum Northwest) in Type 21 quartz cuvette with 10 mm path length (Buck 
Science) by monitoring the change in turbidity at 800 nm from 25°C to 80°C at a rate of 
1°C/min. Protein stock solutions for Tt measurement were prepared in 0.2 mg/mL (or 14.3 
µM and 14.4 µM for CE1-His6 and E1C-His6, respectively) in 10 mM sodium phosphate 
buffer, pH 8.0. In order to bring Tt value of all the samples into instrument operation range, 
highly concentrated NaCl solution was added prior to Tt measurement (Table S1). 
Measurements were performed on at least two different protein sample preps to calculate the 
average Tt. The Tt was determined at the midpoint of the normalized turbidity [39].
Small molecule loading and release
Curcumin (6.5 nmol final concentration from 3 mM stock solution in HPLC grade methanol) 
was incubated with 1.3 nmol of CE1-His6, E1C-His6, CE1-His6-GNP and E1C-His6-GNP at 
room temperature for 2 hours and loaded onto Bio-Rad Spin6 columns packed with 
Sephadex G-25 medium beads 0.5 cm high. Bound protein polymer-curcumin complexes (in 
the presence or absence of GNP) were eluted by size, washed 3 times in 50 µL sodium 
phosphate buffer, followed by centrifugation for 5 min at 14000 rpm. The beads containing 
unbound curcumin were collected separately and resuspended back to buffer for solvent 
extraction. Both bound and unbound curcumin were extracted by adding 150 µL ethyl 
acetate and quantitatively determined by measuring absorbance at 416 nm. Absorbance was 
measured in a Hellma 105.201-QS type cuvette (10 mm light path, 100 µL sample) on 
SpectraMax M2. This binding study was performed on at least three different protein sample 
preparations to calculate the average loading capacities with errors represented as the 
standard deviation of the three trials.
Release of curcumin from CE1-His6, E1C-His6, CE1-His6-GNP and E1C-His6-GNP was 
then investigated. Curcumin (26 nmol) was added to 200 µL of 26 µM (5.2 nmol) protein 
sample. After 2 hours of incubation at room temperature, the solution was adjusted to 
contain a final concentration of 0.5 M NaCl. The protein polymer-curcumin complex (in the 
presence or absence of GNP) were incubated at 45°C (well above the Tt) for 30 min and 
centrifuged to separate protein polymer-curcumin complex from excess curcumin. The 
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pellets were resuspended in 200 µL of 50 mM phosphate buffer, pH 7.4 and kept at room 
temperature in the dark for release. After 10 min, the suspensions were centrifuged and the 
supernatant was removed and used for extraction assessment of released curcumin. This 
resuspension-incubation-spin-release cycle was repeated for the next eight hours at the 
following time points: 10, 25, 55, 85, 135, 195, 255, 315 and 495 min. Release study was 
performed on two different protein sample preparations to obtain the averaged release 
profile. Error bars on the release data represented standard error of the two sample 
preparations.
Cell culture studies
MCF7 human breast cancer cells were obtained from ATCC and maintained at 37°C, 5% 
CO2 as monolayer cultures in Dulbecco’s modified Eagle’s medium (DMEM with high 
glucose containing phenol red) supplemented with 10% (v/v) fetal bovine serum (FBS), 
gentamicin (50 µg/mL), 100 U penicillin/ 100 µg/mL streptomycin. Because the loading 
capacities of curcumin for P-GNP nanocomposites are much larger than those of the proteins 
in the absence of GNP we prepared two corresponding curcumin controls that represented 
the bound curcumin levels in P-GNP and protein polymers alone (Table S2). To avoid any 
uptake of unbound curcumin by the cells directly, we limited the curcumin amount that is 
equivalent to the loading capacity of 26 µM of protein samples in 50 mM sodium phosphate 
buffer, pH 7.4 and allowed to bind for 2 hours at room temperature prior to cell culture 
studies.
Multiple sets of experiments were performed to record curcumin uptake by image 
acquisition using FITC filter (Em: 520 nm) under fluorescence microscopy and direct 
measurement of curcumin uptake in cell extractions. Cells were grown directly on 24-well 
culture plates (8 × 104 cells/well) for cell extraction or on cover slips for microscopy. After 
24 hours of cell plating, cells were treated for 4 or 24 hours with different combination of 
proteins with or without GNP and/or curcumin. For all the treatments, the total volume of 
samples with DMEM in 24-well plates was kept constant at 300 µL, with proteins prepared 
at 10 µM concentrations. The ratio of sample amount to number of cells was also kept 
constant. The results are representative of two such independent sets of experiments.
For direct measurement of curcumin uptake, cells were washed with Dulbecco’s phosphate 
buffered saline and lysed with 200 µL RIPA/ well (25 mM TrisHCl pH7.6, 150 mM NaCl, 
1% NP-40, 1% sodium deoxycholate, 0.1% SDS) at room temperature for 20 min with 
gentle shaking. Lysed cells were then collected and vortexed. For curcumin extraction, 150 
µL ethyl acetate was added the lysed cells. Thorough extraction was ensured by violently 
shaking the lysate-solvent mixture for 30 seconds. Curcumin containing solvent phase was 
then separated by centrifuging at 14,000 RPM for 2 minutes at room temperature. 
Absorbance of curcumin in ethyl acetate was measured using SpectraMax M2 (Molecular 
Devices) in Hellma 105.201-QS type quartz cuvette (100 µL volume, 10 mm light path) at 
416 nm [40,41].
For fluorescent imaging of curcumin uptake, cells on coverslips were fixed with 300 µL 4% 
paraformaldehyde solution in DPBS for 20 minutes at room temperature on a plate rocker 
[42]. Following fixation, cell-containing coverslips were washed 3 × 300 µL DPBS and were 
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mounted on glass slides using DAPI containing mounting medium (Southern Biotech Dapi 
Fluoromount-G). Coverslips were then sealed using clear nail polish for viewing under 
microscopy and long-term storage. Cells were viewed using fluorescence microscope IX71 
(Olympus) using DAPI (for cell nuclei) and FITC (for curcumin uptake) at 60× 
magnification while keeping the exposure time for the FITC images constant at 200 
milliseconds.
Cell viability measurements were carried out using a CellTiter 96® Aqueous One solution 
kit (Promega) in a 96-well plate, seeded 1 × 104 cells/well. After 24 hours, the cells were 
treated for 4 hours or 24 hours with protein polymers and P-GNP nanocomposites with and 
without curcumin along with control treatments of curcumin alone and media alone. After 
the treatment periods, 20 µL [3–(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium (MTS) was added to each well, followed by incubation at 
37°C for 3 hours. The plate was centrifuged for 3 minutes at 2500 rpm and then subjected to 
absorbance measurements at 490 nm (Tables S3 and S4).
Results
Fabrication of P-GNP nanocomposites
Both CE1-His6 and E1C-His6 were biosynthesized through recombinant bacterial expression 
and purified via nickel affinity resin. The protein diblock polymers were subject to GNP 
templated-synthesis without use of capping reagents. Gold salt (HAuCl4) solution was 
directly added to protein samples [24,25], followed by reduction with NaBH4 [43] under pH 
6 and 8 (Figure 2a). Surprisingly, the P-GNP nanocomposites were stable at pH 8; within 
one week, absorbance spectra of complexes remained nearly the same with no observed 
precipitation even after one month when stored at room temperature (data not shown). The 
CE1-His6-GNP and E1C-His6-GNP exhibited successful templated-synthesis of GNPs with a 
distinct red-brown color change, confirmed by an observable peak at ~520 nm under pH 8 
(Figure 2a). Since the lone pair electron on ε2N of histidine is protonated at pH ≤ 6, the 
protein polymer did not undergo GNP templated-synthesis very well under pH 6 conditions, 
consistent with literature [26]. Both CE1-His6 and E1C-His6 in the absence of gold salt did 
not lead to any detectable absorption peak at 520 nm (Figure S3); gold salt in the absence of 
protein did not produce signal indicating that the protein polymers were necessary for GNP 
templated-synthesis (Figure 2a). To affirm that the GNP templated-synthesis was due to the 
His6 tag, proteins lacking the N-terminal His6 sequence did not exhibit a strong signal at 520 
nm (Figure S3).
Morphological characterization of P-GNP nanocomposites
To assess the morphology and sizes of the P-GNP nanocomposites, transmission electron 
microscopy (TEM) was performed (Figures 2b and 2c). As expected [31], the CE1-His6-
GNP and E1C-His6-GNP assembled into nanoparticles with diameters of 23.8 ± 5.6 nm and 
23.9 ± 5.2 nm, respectively (Table 1 and Figure S4). Average diameters of GNPs in both 
CE1-His6-GNP and E1C-His6-GNP were 3.4 ± 0.9 nm and 3.5 ± 0.9 nm, respectively (Table 
1 and Figure S5). Consistent with published work, the observed absorption peak at 520 nm 
is due to the GNP diameters being within 2–10 nm range (Figure S6) [44].
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Secondary structure analysis of P-GNP nanocomposites
A comparison of the secondary structures in the presence and absence of GNP was 
performed via circular dichroism (CD) to determine whether GNP templated-synthesis 
affected the protein polymer conformations (Figure 3a). While the overall shape of the 
wavelength scans were maintained, a slight loss in structure was observed for CE1-His6-
GNP and E1C-His6-GNP relative to CE1-His6 and E1C-His6, respectively (Figures 3a, S7 
and S8). To assess the impact of GNP templated-synthesis on the inverse temperature 
transition (Tt), the UV/vis absorbance of CE1-His6-GNP and E1C-His6-GNP at 800 nm was 
monitored as a function of temperature (Table 1). Relative to the parent protein polymers, 
CE1-His6-GNP and E1C-His6-GNP revealed an increase in Tt by 11.2°C and 8.3°C, 
respectively.
Curcumin loading and release
To evaluate the loading capacity of the protein polymers in the absence and presence of 
GNP, curcumin was incubated with CE1-His6, E1C-His6, CE1-His6-GNP and E1C-His6-GNP 
for 2 hours. Unbound curcumin was then separated and quantified to determine the amount 
of curcumin bound to the protein polymer and P-GNP complexes (Table 1). Surprisingly, 
CE1-His6-GNP exhibited higher binding capacity than CE1-His6 by 8 fold, while E1C-His6-
GNP demonstrated a 7.3 fold improvement over E1C-His6.
Release studies were performed by loading the protein polymers and P-GNPs with curcumin 
and assessing the amount of free curcumin over time. The protein polymers alone released 
>50% curcumin after 1.4 hours; both CE1-His6 and E1C-His6 showed rapid and nearly 
complete release of 77.0% and 78.8% free curcumin by 8.25 hours (Figure 3b). By contrast, 
CE1-His6-GNP and E1C-His6-GNP, revealed a slow and sustained release of 27.9% and 
18.8% free curcumin by 8.25 hours (Figure 3b). Thus, the P-GNP nanocomposites not only 
increased the binding capacity for curcumin but also, slowed down its release.
Curcumin uptake by breast cancer cells
As curcumin is insoluble under aqueous conditions and does not effectively penetrate cancer 
cells alone [40], we investigated whether the P-GNP nanocomposites could enhance small 
molecule delivery and uptake by MCF7 breast cancer cells. Both CE1-His6-GNP and E1C-
His6-GNP complexed with curcumin exhibited uptake as visualized by fluorescence (FITC 
channel); the curcumin appeared to be present in the cytoplasm as demonstrated by the 
overlay with DAPI stained cells (Figure 4). We also explored whether the protein polymers 
alone would deliver curcumin; both CE1-His6 and E1C-His6 revealed uptake albeit 
substantially less than the P-GNP nanocomposites (Figure 4). To assess whether CE1-His6-
GNP, E1C-His6-GNP, CE1-His6 and E1C-His6 were themselves toxic to the cells, MTS 
assays were conducted; neither the protein polymer or P-GNP nanocomposites exhibited 
cytotoxicity (Table S3 and S4). Under identical conditions, the curcumin alone control did 
not show any uptake at the same concentrations of the protein polymers alone and the P-
GNP nanocomposites. This was confirmed by quantifying curcumin extracted from the cells. 
Extraction of curcumin revealed 2.25-fold and 3.75-fold greater amount of available 
curcumin for CE1-His6-GNP and E1C-His6-GNP, respectively, relative to the protein 
polymers alone (Figure 5).
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Discussion
Gold nanoparticle templated-synthesis influence on secondary structure and inverse 
temperature transition
We have produced stable P-GNP nanocomposites by GNP templated-synthesis through 
engineered N-terminal hexahistidine sequences within the protein diblocks CE1-His6 and 
E1C-His6. Either removing the hexahistidine sequence or decreasing the pH to alter the 
protonation state of the histidine residues does not lead to GNP production (Figure 2). After 
confirming GNP templated-synthesis to CE1-His6 and E1C-His6 spectroscopically, 
secondary structure analysis reveals that although a slight loss in alpha helicity is observed, 
the nanocomposites maintain overall conformation (Figure 3a). While in situ GNP 
templated-synthesis does not dramatically alter the protein polymer conformations, it does 
impact their thermoresponsive behavior. The marked effects on the thermoresponsiveness 
upon GNP templated-synthesis by the CE1-His6 and E1C-His6 protein polymers, regardless 
of the orientation of the domains can explain the improved loading capacity for curcumin. 
Upon GNP templated-synthesis, the P-GNP nanocomposites possessed elevated inverse 
temperature transitions (Table 1), indicative of heightened resistance to coacervative 
temperature-induced conformation changes. The enhanced stability against coacervation 
could impose greater mobility via increased hydration on the P-GNP nanocomposites 
thereby exposing more non-specific sites for curcumin binding leading to improved loading 
capacity.
Small molecule binding properties after gold nanoparticle templated-synthesis and in vitro 
delivery
The C domain present in both diblocks CE1-His6 and E1C-His6 is capable of binding small 
hydrophobic molecules such as curcumin [31]. This phytochemical possesses medically 
relevant pharmacological properties yet it fails to remain stable under physiological 
conditions [29]. Therefore, maximizing curcumin loading capacities and optimizing slower 
release profiles in carriers would be important for drug delivery. Upon GNP templated-
synthesis of both protein diblocks with gold nanoparticles, there is a 7.3 and 8-fold increase 
in curcumin binding for CE1-His6-GNP and E1C-His6-GNP, respectively, when compared to 
the protein polymers alone (Table 1). Curcumin is interesting in that it only exhibits 
fluorescence upon binding to other molecules [40]. The curcumin bound P-GNP 
nanocomposites show quenching and a blue shift in the fluorescence spectra suggesting a 
proximity effect of the GNP on the fluorescence properties of curcumin (Figure S9). This 
further affirms that the P-GNP nanocomposites are binding to the curcumin.
The P-GNP nanocomposites demonstrate a prolonged release profile whereby nearly 70% of 
available curcumin was retained within both the P-GNP nanocomposites after 8.25 hours 
(Figure 3b). In contrast, the protein polymers alone released more than 50% of retained 
curcumin after 1.4 hours. The prolonged release profile could be due to: i) the binding of 
curcumin to GNPs and ii) the stabilization or increase in Tt observed upon GNP templation 
as mentioned. Previous work has demonstrated the ability of GNPs to bind small molecules 
directly [45], suggesting that the enhanced binding capacity of the P-GNP nanocomposites 
for curcumin could be attributed to the GNPs. The improved binding and stability provided 
Dai et al. Page 9
J Nanomed Nanotechnol. Author manuscript; available in PMC 2016 April 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
by the GNP templation (Table 1), could cause to the prolonged release profile. These results 
translate to successful delivery into MCF-7 cells.
While it is unclear whether CE1-His6, E1C-His6, CE1-His6-GNP and E1C-His6-GNP get 
taken up by the cells, there is an improved delivery of curcumin by the P-GNP 
nanocomposites. Extraction of curcumin from treated MCF-7 cells reveals a greater than 2-
fold increase in bioavailable phytochemical by both the nanocomposites relative to their 
protein polymers counterparts (Figures 5a and 5b). The high amount of curcumin recovered 
from the cells implies chemical protection and half-life extension of the labile, yet 
biologically active curcumin.
Conclusions
Remarkably, both CE1-His6-GNP and E1C-His6-GNP nanocomposites exhibit improved 
small molecule loading, slow and extended release as well as effective delivery when 
exposed to MCF-7 breast cancer cells. Further efforts are underway to elucidate the 
mechanisms by which P-GNP nanocomposites impact small molecule binding and releasing 
profile. These hybrid constructs can greatly broaden the biomaterials candidates for 
applications in targeted drug delivery. This can be achieved via the incorporation of tumor 
targeting domains in the solvent exposed residues of the protein polymer [46–48]. 
Furthermore, the drug loaded-nanocomposites, by way of templated-synthesis of GNP on 
the protein polymer, could be used for tandem chemotherapy and light-irradiated 
phototherapy [10,20,48].
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Protein polymer sequences of CE1-His6 and E1C -His6 and gold nanoparticle (GNP) 
templated-synthesis strategy.
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Figure 2. 
In situ gold nanoparticle (GNP) templated-synthesis by protein polymer sequences. (a) UV-
Vis spectrum of protein polymer-GNP nanocomposites at pH6 and pH8 (inset shows the 
templated-synthesis products of CE1-His6-GNP pH6 (I), E1C-His6-GNP pH6 (II), CE1-His6-
GNP pH8 (III), E1C-His6-GNP pH8 (IV) and phosphate buffer-GNP pH8 (V)). TEM of (b) 
CE1-His6-GNP and (c) E1C-His6-GNP at pH8.
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Figure 3. 
(a) CD wavelength scans of protein polymers in the absence and presence of GNP. (b) 
Accumulated release of CCM as a function of time.
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Figure 4. 
Fluorescence microscopy images of MCF-7 cells treated with protein polymers alone or P-
GNP nanocomposites in the absence and presence of curcumin (CCM).
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Figure 5. 
Quantification of uptake via extraction from cells. Absorption plots of (a) CE1-His6-CCM 
(black) CE1-His6-GNP-CCM (red), and CCM (blue) (p value < 0.05) and (b) E1C-His6 
(black) E1C-His6-GNP-CCM (red) and CCM (blue) (p value < 0.05).
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Table 1
Particle sizes, Tt and Loading capacities of proteins in the presence and absence of GNPs.
Composite Size of
protein
particles
(nm)
Size of GNPs
(nm)
Tt (°C) CCM/Pc molar
binding ratio
CE1-His6 26.0 ± 3.0a N/A 55.0 ± 0.8 0.40 ± 0.06
E1C-His6 27.9 ± 3.7a N/A 33.8 ± 2.2 0.41 ± 0.10
CE1-His6-
GNP
23.8 ± 5.6b 3.4 ± 0.9 66.2 ± 0.8 3.16 ± 0.44
E1C-His6-
GNP
23.9 ± 5.2b 3.5 ± 0.9 42.1 ± 7.1 2.95 ± 0.42
a
Data from (ref 28).
bSizes were measured on P-GNP nanocomposites from > 130 particles.
c
Ratio of Curcumin to protein or P-GNP.
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